COVID-19 pandemic It is announced that the Merck & Co. antiviral drug molnupiravir will be available to Philippine patients after an agreement was signed between the Office of the Vice President of the Philippines and a local health care provider after the Food and Drug Administration gave a compassionate special permit for the drug. Sources: Philippine Daily Inquirer